Bristol Myers Squibb Gross Profit 2006-2021 | BMY

Bristol Myers Squibb annual/quarterly gross profit history and growth rate from 2006 to 2021. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Bristol Myers Squibb gross profit for the quarter ending September 30, 2021 was $9.333B, a 16.11% increase year-over-year.
  • Bristol Myers Squibb gross profit for the twelve months ending September 30, 2021 was $34.974B, a 24.73% increase year-over-year.
  • Bristol Myers Squibb annual gross profit for 2020 was $30.745B, a 70.17% increase from 2019.
  • Bristol Myers Squibb annual gross profit for 2019 was $18.067B, a 12.26% increase from 2018.
  • Bristol Myers Squibb annual gross profit for 2018 was $16.094B, a 9.02% increase from 2017.
Bristol Myers Squibb Annual Gross Profit
(Millions of US $)
2020 $30,745
2019 $18,067
2018 $16,094
2017 $14,762
2016 $14,458
2015 $12,651
2014 $11,947
2013 $11,766
2012 $13,011
2011 $15,646
2010 $14,207
2009 $13,668
2008 $12,399
2007 $10,698
2006 $10,788
2005 $12,868
Bristol Myers Squibb Quarterly Gross Profit
(Millions of US $)
2021-09-30 $9,333
2021-06-30 $9,251
2021-03-31 $8,232
2020-12-31 $8,158
2020-09-30 $8,038
2020-06-30 $7,430
2020-03-31 $7,119
2019-12-31 $5,453
2019-09-30 $4,217
2019-06-30 $4,301
2019-03-31 $4,096
2018-12-31 $4,363
2018-09-30 $4,043
2018-06-30 $4,079
2018-03-31 $3,609
2017-12-31 $3,848
2017-09-30 $3,675
2017-06-30 $3,575
2017-03-31 $3,664
2016-12-31 $3,837
2016-09-30 $3,617
2016-06-30 $3,665
2016-03-31 $3,339
2015-12-31 $3,335
2015-09-30 $2,972
2015-06-30 $3,150
2015-03-31 $3,194
2014-12-31 $3,292
2014-09-30 $2,914
2014-06-30 $2,898
2014-03-31 $2,843
2013-12-31 $3,168
2013-09-30 $2,890
2013-06-30 $2,940
2013-03-31 $2,768
2012-12-31 $3,116
2012-09-30 $2,749
2012-06-30 $3,198
2012-03-31 $3,948
2011-12-31 $4,087
2011-09-30 $3,938
2011-06-30 $3,953
2011-03-31 $3,668
2010-12-31 $3,697
2010-09-30 $3,518
2010-06-30 $3,491
2010-03-31 $3,501
2009-12-31 $3,600
2009-09-30 $3,471
2009-06-30 $3,440
2009-03-31 $3,157
2008-12-31 $1,925
2008-09-30 $3,620
2008-06-30 $3,533
2008-03-31 $3,321
2007-12-31 $1,535
2007-09-30 $3,123
2007-06-30 $3,063
2007-03-31 $2,977
2006-12-31 $1,596
2006-09-30 $2,689
2006-06-30 $3,303
2006-03-31 $3,200
2005-12-31 $3,013
2005-09-30 $3,284
2005-06-30 $3,406
2005-03-31 $3,165
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $125.010B $42.518B
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes and sells biopharmaceutical products. It offers products which includes hematology, oncology, cardiovascular and immunology. Bristol-Myers Squibb Company, formerly known as Bristol-Myers Company, is based in New York.
Stock Name Country Market Cap PE Ratio
Bio-Rad Laboratories (BIO.B) United States $22.443B 45.55
QIAGEN (QGEN) Netherlands $12.357B 20.93
Biohaven Pharmaceutical Holding (BHVN) United States $6.783B 0.00
Arcus Biosciences (RCUS) United States $3.105B 0.00
Emergent Biosolutions (EBS) United States $2.254B 8.10
ADC Therapeutics SA (ADCT) Switzerland $1.478B 0.00
Myovant Sciences (MYOV) United Kingdom $1.368B 0.00
Zymeworks (ZYME) Canada $0.861B 0.00
Ambrx Biopharma (AMAM) United States $0.337B 0.00
SQZ Biotechnologies (SQZ) United States $0.319B 0.00
Enzo Biochem (ENZ) United States $0.162B 15.90